NCT03306628

Early Carbon Dioxide Laser Therapy for Alleviation of Incisional Scar Burden

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: NYU Langone Health · Academic / Other
• Sex: Female
• Age: 21 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, randomized pilot study of patients who will undergo either early or late incisional laser therapy after breast reduction surgery to alleviate scar burden at NYU Langone Medical Center. The purpose of this study is to see how well carbon dioxide (CO2) laser therapy works at preventing scar formation after surgery.CO2 laser therapy is currently being used by dermatologists and plastic surgeons to help with scarring after acne and to rejuvenate the face; its benefits are now being explored by medical professionals in dermatology and cosmetic surgery to prevent scarring after surgery.

Conditions

• Skin Scarring

Interventions

Type	Name	Description
OTHER	CO2 Laser Administration	The CO2 fractional laser system will be applied at a pulse energy setting of 50 millijoules and a density of 100 spots/cm2 on one of the breast incisions (either one week after surgery or six weeks after surgery, depending on the randomization group).

Timeline

• Start date: 2017-11-15
• Primary completion: 2019-08-26
• Completion: 2019-08-26
• First posted: 2017-10-11
• Last updated: 2020-01-06

Locations

1 site across 1 country: United States